Imerys S.A. and Omya AG have entered into exclusive negotiations to form a 50:50 technology joint venture to promote the research and development of Micro Fibrillated Cellulose (MFC) concerning a variety of applications and industries.

纸浆

Imerys and Omya entered into negotiations to form a technology joint venture

Feb 29, 2016. /Lesprom Network/. Imerys S.A. and Omya AG have entered into exclusive negotiations to form a 50:50 technology joint venture to promote the research and development of Micro Fibrillated Cellulose (MFC) concerning a variety of applications and industries, as Imerys said in the press release received by Lesprom Network.

The venture will combine the FiberLeanTM and Omya’s MFC technology platforms developed by each company into one entity, henceforth to be known as FiberLeanTM Technologies.

The first commercial product available, which has already been granted a Food Contact Notification (FCN) by the US Food and Drug Administration, allows paper & packaging producers to improve quality and/or increase the mineral filler loading to achieve productivity gains and reduced costs.

The commercialization of MFC is to be independently and separately undertaken by Imerys and Omya commercial teams making the technology easily accessible to customers across various industries.

Micro and Nano Cellulosics are renewable, sustainable engineered materials with the potential to deliver exceptional performance and value to a wide range of industrial and consumer markets. FiberLeanTM Technologies will expand its process and application technology to deliver such products and solutions.